Site Search
Search Results
Advocates Hold Cancer Action Day at State House, Urging Lawmakers to Expand Access to Biomarker Testing & Address Affordability Concerns
CONCORD, NH —March 6, 2025— Earlier today, American Cancer Society Cancer Action Network (ACS CAN) volunteers rallied at the New Hampshire State House as a part of their annual Cancer Action Day advocating for several legislative proposals that aim to address the needs of patients across the cancer ... Specifically, the advocates urged support of a proposal to improve access to biomarker testing (SB 120) and legislation relative to insurance cost sharing calculations (SB 17). They also asked lawmakers to protect level funding for the state’s Tobacco Control & Cessation Program, the ...
Expand Access to Biomarker Testing in New Hampshire
Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more New Hampshire residents can benefit from this important testing. What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ biomarker ” is a sign of a normal biological process, disease or abnormal function that can be measured in blood, tissue or bodily fluid. Biomarker testing is the analysis of a patient’s tissue, blood or other biospecimen for the presence of a biomarker. Political action is needed to ensure more Granite Staters ...